Macromolecular drug transport into the brain using targeted therapy

Area of Science:

• Neuroscience
• Pharmacology
• Biotechnology

Background:

• The brain is protected by the blood-brain barrier (BBB) and blood-CSF barriers, which restrict drug entry.
• These barriers limit therapeutic options for CNS disorders by preventing passage of large molecules.
• The BBB is the primary obstacle due to its large surface area.

Purpose of the Study:

• To review strategies for targeted delivery of macromolecules into the brain.
• To explore methods for overcoming the BBB and blood-CSF barriers for drug transport.
• To discuss the challenges and evidence for transporting therapeutic molecules across the BBB.

Main Methods:

• Literature review of existing research on brain barrier systems and drug delivery.
• Analysis of targeting strategies involving specific molecular interactions with barrier cells.
• Evaluation of evidence for drug carrier transport across the BBB.

Main Results:

• The BBB poses a significant challenge to drug delivery due to its structure and function.
• Targeting molecules can be designed to interact with specific proteins on barrier cells.
• Evidence for successful transport of targeted drug carriers across the BBB remains debated.

Conclusions:

• Overcoming the BBB is crucial for developing effective CNS therapies.
• Targeted delivery systems offer potential but require further validation.
• Research continues to explore and refine methods for brain drug delivery.